Monday, 15 June 2020

Exclusive: Germany to take stake in unlisted CureVac - sources

Germany will take a stake in unlisted biotech firm CureVac, which is working on a COVID-19 vaccine, four people familiar with the plan told Reuters on Monday.


No comments:

Post a Comment